福龍馬(603686.SH):擬推第四期員工持股計劃
格隆匯4月13日丨福龍馬(603686.SH)公佈,第四期員工持股計劃的資金來源於公司計提的業績激勵基金,公司提取的2022年度(當期)業績激勵基金的總額為130.93萬元,不超過2022年度經審計扣除非經常性損益前歸屬於母公司所有者的淨利潤的15%。
第四期員工持股計劃的股票來源為公司回購專用證券賬户剩餘的已回購福龍馬A股股票,不超過22.53萬股,佔公司總股本的0.05%。
第四期員工持股計劃受讓公司回購股票的價格為公司審議本期員工持股計劃的董事會召開之日前20個交易日公司股票均價9.96元/股的90%,確定為8.97元/股。第四期員工持股計劃涉及的標的股票數量預計不超過14.6萬股,佔公司總股本的0.04%,最終持有的標的股票數量以公司過户及披露的為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.